Montreal, Canada
Ditch Labs, founded in 2020 and headquartered in Canada, is a cutting-edge company in the fields of AI, Health Care, Medical Devices, and Pharmaceutical industries. The company is renowned for its slogan: "A digital health company pioneering nicotine addiction treatment with artificial intelligence and a revolutionary device".
With the recent completion of a $3.50M Seed Round investment on July 12, 2023, Ditch Labs secured backing from a diverse group of investors, including Anges Québec, Capital Angel Network, Amplify Capital, Investissement Québec, Boreal Ventures, Meditrial, Symphony Care Network, and Kale Investment Fund.
Their unique product solution features a proprietary medical device integrated with a digital therapeutic application, targeting both the physiological and psychological facets of nicotine addiction. This dual-pronged strategy positions Ditch Labs at the forefront of the digital health landscape, offering investors a compelling opportunity in a rapidly evolving market.
